|
09:00 to
04:00
Course by Tim Albert. “How to get your paper written and published”.
|
|
04:30
to 07:00
True to Live Surgery. Session moderated by Giampaolo Gini
|
|
|
|
07:30
|
|
Welcome
Reception at the Conventum |
|
|
|
Sunday, June 19th
|
|
Macula
Pot Pourri
|
|
08:15
|
|
Opening
|
|
08:30
|
|
An unusual large tractional
macular break. Salim
Ben Yahia
|
|
08:36
|
|
One port PPV for ERM treatment:slit lamp & new AC maintainer in phakic patients. Cesare Forlini
|
|
08:43
|
|
Treatment of macular detachment
in patients with optic pit. Sven
Crafoord
|
|
08:53
|
|
Vitrectomy for optic pit-related
retinal detachment. Ferenc
Kuhn
|
|
09:03
|
|
Temporal RON for optic disc
pit associated with macular detachment. Murat
Karacorlu
|
|
09:10
|
|
Industry Announcement BAUSCH
& LOMB
|
|
09:15
|
|
Hemorrhagic macular
cysts in Terson syndrome. Ferenc Kuhn
|
|
09:23
|
|
Macular bleeding associated
with sexual activity in patient receiving anticoagulants. Salim BenYahia
|
|
09:31
|
|
Therapeutic effect of propranolol
on central serous chorioretinopathy. Ali Reza Ramezani
|
|
09:37
|
|
Results of PDT for idiopathic
polypoidal choroidal vasculopathy. S.
Natarajan
|
|
09:45
|
|
OCT in active choroidal
neovascularization secondary to pathologic
myopia. Murat Karacorlu
|
|
09:52
|
|
Discussion moderated by Khaled El Rakhawy
|
|
ARMD Medical
Treatment
|
|
10:45
|
|
The RPE in health and disease:
a role for lipofuscin and melanin in ARMD. Mike Boulton
|
|
11:00
|
|
Neoangiogenesis in
ARMD. Lennart Berglin
|
|
11:15
|
|
Is vitreous adhesion a risk
factor for CNV in AMD? Martine
Mauget-Faÿsse
|
|
11:23
|
|
Preferential Hyper acuity Perimeter:
clinical and angiographic correlations. Guy
L’Helgoual’ch
|
|
11:31
|
|
Variations of the visual function
according to the therapy. Christian
Malbrel
|
|
11:37
|
|
One year results of PDT in
eyes with choroidal neovascular membranes
due to ARMD. Tugrul
Altan
|
|
11:43
|
|
Industry Announcement ALCON
|
|
11:48
|
|
Encouraging results of PDT
with verteporfin in a clinical patient material of ARMD.
Christina Frennesson
|
|
11:58
|
|
PDT in the treatment of retinal
angiomatous proliferation. Marcio Nehemy
|
|
12:06
|
|
PDT for CNV in juvenile disciform
macular degeneration. Case report of 4 Icelandic cases. Ingimundur Gislason
|
|
12:15
|
|
Industry Announcement NOVARTIS
|
|
12:20
|
|
Discussion moderated by Christina Frennesson.
Related posters (Melanie Chak
and Claudia Kuhli)
|
|
|
|
|
|
02:00
|
|
Photodynamic therapy with visudyne:
complications. Guy L ‘Helgoual’ch
|
|
02:10
|
|
Histological characteristics
of neovascular membranes in AMD after PDT:
Comparison with spontaneous evolution, laser photocoagulation,radiotherapy. Didier
Ducournau
|
|
02:18
|
|
Combined treatment: PDT with
visudyne and IVT. Guy L’Helgoual’ch
|
|
02:28
|
|
Industry Announcement
CARL
ZEISS MEDITEC
|
|
02:33
|
|
Unicentric, randomized, open, parallel study
of comparison of PDT V/s IVT S. Natarajan
|
|
02:43
|
|
OCT evaluation of serous PED
after IVT and PDT for exudative ARMD.
Murat Karacorlu
|
|
02:53
|
|
Industry Announcement
ALCON
|
|
02:58
|
|
Anecortave acetate depot suspension for treatment
of exudative ARMD. Marc de Smet
|
|
03:06
|
|
Industry Announcement NOVARTIS
|
|
03:12
|
|
Rheopheresis to eradicate the drusen - CNV cascade. Frank
Koch
|
|
03:20
|
|
VEGF inhibition study in ocular
neovascularization: Outcomes from the phase II/III Macugen pivitol trials.Thomas Friberg
|
|
03:28
|
|
Discussion
moderated by Martine Mauget-Faÿsse. Related posters (Timothy W. Olsen)
|
|
04:30 to
06:00
Young EVRS Club
|
|
04:30
to 05:30
Country Delegate Assembly
|
|
04:30
to 05:30
Rosengren Club & Nordic VitreoRetinal Meeting
|
|
|
|
Medieval Thrills at Orebro Castle |
|
Monday, June
20th
|
|
ARMD Surgical
Approach
|
|
08:30
|
|
Surgical extraction of choroidal
neovascular membranes. Ziya Kapran
|
|
08:36
|
|
Current management
of juxtapapilar choroidal
neovascular lesions. Jaume Catala
|
|
08:44
|
|
Combined surgical ablation
and IVT for retinal angiomatous proliferation.
Francesco Boscia
|
|
08:50
|
|
Limited invasive procedures
to treat CNV’s in ARMD. Frank
Koch
|
|
08:58
|
|
Discussion moderated by Klaus Lucke
|
|
09:20
|
|
The use of tPA
in the management of sub-retinal haemorrhages. Theodoros Potamitis
|
|
09:28
|
|
Management of sub macular haemorrhage.
Pietro Rossi
|
|
09:36
|
|
Therapeutic approach to acute
submacular haemorrhage. Ziya Kapran
|
|
09:42
|
|
Vitrectomy and subretinal
tPA in submacular
haemorrhage. Mehmet Cakir
|
|
09:47
|
|
Role of subretinal
R-TPA in management of subretinal haemorrhage
due to ARMD. S. Natarajan
|
|
09:55
|
|
Discussion moderated by Karl Ulrich Bartz-Schmidt.
Related posters (Faruk Eroglu)
|
|
|
|
10:45
|
|
An Update on macular rotation
surgery for large subretinal neovascular
membranes. Klaus Lucke
|
|
11:00
|
|
Four years experience with
macular translocation. Zoran Tomic
|
|
11:06
|
|
New approaches to severe incyclotorsion
induced by macular translocation. Jonathan M. Holmes
|
|
11:14
|
|
Macular translocation in selected
cases of CNV and heavy silicone tamponade.
Cesare Forlini
|
|
11:20
|
|
Surgery for ARMD complicated
by massive subretinal haemorrhage. Nataliya Nehus
|
|
11:28
|
|
Full macular translocation
for massive submacular haemorrhage secondary to exudative
ARMD. Hassan Mortada
|
|
11:36
|
|
Full macular translocation
vs. PDT for Neovascular ARMD – Intermediate results of a prospective,
controlled, randomized pilot study. Karl Ulrich Bartz-Schmidt
|
|
11:46
|
|
Discussion
by Frank Koch.
|
|
12:10
|
|
Relya Zivojnovic
Award. Peep Algvere Lecture: “The challenge
of retinal transplantation.”
|
|
12:40
|
|
RPE and choroid
translocation. Jan Van Meurs
|
|
12:55
|
|
Artificial bruch’s
membrane implant: preliminary results
on animal. Fabio Patelli
|
|
01:01
|
|
Discussion moderated by Sven Crafoord. Related posters (Isabel
Pinilla).
|
|
|
|
|
|
Maculopathies: Pathogenesis,
Functional Testing & Imaging
|
|
02:30
|
|
Pathogenesis of macular edema
in branch retinal vein occlusion. New approach.
Jiri Rehak
|
|
02:38
|
|
Clinicodiagnostic correlation of macular disease. Jerzy Nawrocki
|
|
02:46
|
|
OCT as a screening method for
diabetic macular edema. Maria Sydorova
|
|
02:52
|
|
The value of OCT in AMD.
Urban Eriksson
|
|
03:02
|
|
Serous macular detachment in
diabetic cystoid macular edema. Murat Karacorlu
|
|
03:08
|
|
Macular function after scleral
buckling surgery for recent-onset RD. Patrik Schatz
|
|
03:16
|
|
Pre-and postoperative functional
and anatomical changes in patients with idiopathic ERM. Frank
Becquet
|
|
03:24
|
|
Evaluation of macular activity
using mfERG in patients with BRVO, before and after sheatotomy. Adam
Cywinski
|
|
03:30
|
|
ILM peeling in macular surgery:
a common physiopathological mechanism suggested by functional results.
Jean-François Le Rouic
|
|
03:38
|
|
ILM removal, how does it work?
Didier Ducournau
|
|
03:55
|
|
Discussion moderated by Ferenc Kuhn.
|
|
04:45
|
|
EVRS
General Assembly |
|
|
|
Swedish
Midsummer Nights' celebration |
|
Tuesday, June
21st
|
|
Vitreomacular Interface Visualization
and Surgical Approach
|
|
08:30
|
|
Visualization aids in VR interface
disorders, what does the staining pattern tell us? Silvia
Bopp
|
|
08:40
|
|
PPV with ILM peeling in MH
surgery. Yaprak Banu Unver
|
|
08:45
|
|
Trypan blue assisted removal of ILM and
ERM. Murat
Oncel
|
|
08:53
|
|
Vitreoretinal surgery for
ERM. Nur Acar
|
|
09:00
|
|
The use of Trypan
blue for the staining of the ILM. Why
not? Vincenzo Ferrara
|
|
09:08
|
|
Trypan blue staining for MH and macular
pucker surgery. Jerzy Nawrocki
|
|
09:16
|
|
Industry Announcement ALCON
|
|
09:21
|
|
ILM Peeling with ICG or trypan
blue in MH surgery: a prospective randomized trial. Hans
Hoerauf
|
|
09:31
|
|
RPE protection from ICG staining.
Cesare Forlini
|
|
09:38
|
|
Kenalog assisted removal of ILM in MH surgery. Theodoros Potamitis
|
|
09:42
|
|
Patterns of posterior cortical
vitreous attachment in myopic macular hole RD. Hassan
Mortada
|
|
09:52
|
|
Triam-time: “Parmesan” central vitrectomy
in macular disease. Cesare Forlini
|
|
10:00
|
|
Discussion moderated by Claudio Azzolini
|
|
|
|
|
|
10:50
|
|
Illuminated vitrector, facilitates bimanual
vitrectomy, and benefits in MH surgery without demand for face down.
Jan-Olof Carlsson
|
|
10:58
|
|
ILM surgery: using a new viewing
system without endoillumination. Murat
Oncel
|
|
11:06
|
|
Surgical slit lamp advantages
for macular surgery. Didier Ducournau
|
|
11:13
|
|
Industry Announcement ARCADOPHTA
|
|
11:18
|
|
ILM
removal indications and techniques.
Ferenc Kuhn
|
|
11:26
|
|
The FILMS procedure for ILM
atraumatic removal. Ferenc
Kuhn
|
|
11:31
|
|
Taut posterior hyaloid
removal in diabetic macular edema. Ziya Kapran
|
|
11:38
|
|
Industry Announcement CORNEAL
|
|
11:43
|
|
Management of thick fibrovascular
membrane with plasma blade. Indu Singh
|
|
11:51
|
|
Posterior vitreous detachment
induced by plasmin enzyme during surgery. Claudio Azzolini
|
|
12:00
|
|
Discussion moderated by Etienne Bovey.
|
|
|
|
|
|
Sutureless Vitrectomy
|
|
01:40
|
|
25g sutureless
surgery for macular pucker. Athanasios Nikolakopoulos
|
|
01:44
|
|
25g sutureless
vitrectomie for post cataract cystic macular edema. Athanasios
Nikolakopoulos
|
|
01:50
|
|
Combined water phaco
fragmentation and 25g surgery for macular pucker. Athanasios
Nikolakopoulos
|
|
01:56
|
|
Industry Announcement ALCON
|
|
02:01
|
|
25G vitrectomy for ERM and
vitreo-macular traction syndromes: short-term results.
Anne-Catherine Gribomont
|
|
02:10
|
|
Short term functional and
anatomic changes after 25G vitreoretinal surgery for ERM. Francesco Boscia
|
|
02:18
|
|
Industry Announcement BAUSCH
& LOMB
|
|
02:23
|
|
Outcomes following 25-Gauge
Vitrectomies For Primarily Macualr Diseases.
Colin McCannel
|
|
02:31
|
|
Our experience with new techniques
in macular surgery: 25-G and 23-G. Zoran Tomic
|
|
02:40
|
|
Industry Announcement DORC
|
|
02:45
|
|
”25g vitrectomy with topical
anaesthesia”. Ioannis Theocharis
|
|
02:53
|
|
Combined sutureless
cataract and vitreous surgery. Márcio Nehemy
|
|
03.00
|
|
Discussion moderated by Anne Catherine Gribomont
|
|
|
|
|
|
Vitreomacular Interface Surgical
Outcomes
|
|
03:50
|
|
Clinical course and results
of surgical treatment of ERM. Viktoria Mester
|
|
03:58
|
|
ERM surgery: with and without
ILM peeling. Murat Oncel
|
|
04:04
|
|
Macular ERM with spontaneous
partial detachment. Etienne Bovey
|
|
04:12
|
|
ILM removal on stage1 macular
hole. Mario Pacini
|
|
04:20
|
|
Industry Announcement TOPCON
|
|
04:25
|
|
OCT in choice of tactics of
surgical treatment for initial stages of idiopathic MH. Oleg
Ulasevich
|
|
04:31
|
|
ILM removal in idiopathic
MH versus myopic MH; differences in technique and results.
Khaled El-Rakhawy
|
|
04:39
|
|
Industry Announcement GEUDER
|
|
04:44
|
|
Sparkling Technique.
Didier Ducournau
|
|
04:53
|
|
Is face down positioning necessary
in MH surgery? Jan-Olof Carlsson
|
|
05:01
|
|
Does using IVT during ILM
peeling affect the outcome of MH surgery? Murat
Karacorlu
|
|
05:07
|
|
Results of surgery in traumatic
MH. Tugrul Altan
|
|
05:14
|
|
Discussion moderated by Silvia Bopp.Related posters (Man-Seong Seo, S.Natarajan,
Cesare Forlini,
Andriy Ruban
and Stephan Winder)
|
|
|
Cocktail
and Gala Dinner at the Conventum |
|
Wednesday, June
22nd
|
|
How
Effective is Triamcinolone in Maculopathies?
|
|
08:30
|
|
The many faces of triamcinolone.
Giampaolo Gini
|
|
08:40
|
|
IVT for DME: Primary Vs Secondary.
Balakrishna Vineeth Kumar
|
|
08:48
|
|
Confounding factors on the
effect of IVT for refractory DME. Ali
Reza Ramezani
|
|
08:56
|
|
IVT acetonide
injection for the management of DME. Mehmet
Cakir
|
|
09:02
|
|
Regression of serous macular
detachment after IVT. Murat Karacorlu
|
|
09:08
|
|
IVT for diabetic massive macular
hard exudates. Salim Ben Yahia
|
|
09:16
|
|
IVT acetonide
injection for the management of BRVO. Nur Acar
|
|
09:22
|
|
Different effect of IVT in
the management of ME secondary to perfusion type and ischemic type BRVO.
Yun-Sik Yang
|
|
09:28
|
|
The effect of IVT on optic
nerve head topography. Yusuf Akar
|
|
09:34
|
|
Discussion moderated by Giampaolo Gini. Related
posters (Jaroslava Dusova, Murat Karacorlu and Yusuf Akar)
|
|
|
|
|
|
Surgical
Treatment of Macular Edema
|
|
10:40
|
|
Laser treatment for macular
edema. Elisabeth Agardh
|
|
10:50
|
|
The natural history of DME:
literature review and personal experience. Barbara Parolini
|
|
11:00
|
|
Vitrectomy versus natural
history for non-tractional DME: the Vide Study. Giacomo Panozzo
|
|
11:10
|
|
Vitrectomy for chronic pseudophakic
cystoid macular edema. Maria
Stefaniotou
|
|
11:18
|
|
Clinical outcome after vitrectomy
with or without ILM peeling in PDR patients with DME. Lars
- Olof Hattenbach
|
|
11:26
|
|
Results and complications
of vitrectomy and ILM removal in the treatment of ME. Ferenc
Kuhn
|
|
11:34
|
|
Macular edema in BRVO. Early
treatment with laser arteriolar constriction technique. New
approach. Jiri
Rehak
|
|
11:42
|
|
Use of YAG-laser retinopuncture
for the treatment of CME caused by thrombosis of central retinal vein
and its branches.
Igor Malov
|
|
11:48
|
|
Comparative study of surgical
and conservative MD of vascular occlusions. Indu Singh
|
|
11:56
|
|
Industrial Announcement
|
|
12:01
|
|
OCT evaluation of macular
edema after RON in patients affected by CRVO. Fabio
Patelli
|
|
12:07
|
|
Discussion moderated by Claude Boscher. Related
posters (Man-Seong Seo,
Sadhna Vora, Maria Stefanioutou,
Eman Kahtani and
Niklas Karlsson)
|
